Hemogenyx Pharmaceuticals PLC Announces Convertible Loans Repayment
Hemogenyx Pharmaceuticals plc (“Hemogenyx Pharmaceuticals” or the “Company”) Convertible Loans Repayment As originally announced in October 2018, Hemogenyx-Cell S.A. (“Hemogenyx-Cell”) and Immugenyx LLC (“Immugenyx”), each wholly-owned subsidiaries of Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, each entered into separate convertible loan